secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-03-24T23:59:59+00:00
Accession:  0001829126-25-002001
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel raises $1M via Series E convertible preferred stock; extends cash runway to Q3 2025
--------------------------------------------------------------------------------

- Gross proceeds of $1.0M from sale of 1M shares of Series E Convertible Preferred Stock at $1.00 per share.
- Each Series E share convertible into 110 common shares, subject to stockholder approval per Nasdaq rules.
- Offering closed on March 21, 2025; net proceeds for working capital and general corporate purposes.
- Cash runway extended into third quarter 2025 based on current operating assumptions.
- Securities sold under Regulation S exemption, no placement agent used.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625002001/0001829126-25-002001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625002001/cyclacel_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-002001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer